Read about NIAID’s investigation of whether a VSV-based Ebola vaccine for people could pose a threat to livestock.
Ebola and Marburg hemorrhagic fevers are acute viral diseases that often lead to severe illness and death in humans and other primates. The infections typically affect multiple organs in the body and are often accompanied by hemorrhage (bleeding). Once the virus has been transmitted from an animal host to a human, it can then spread through person-to-person contact.
Researchers in the NIAID Division of Intramural Research and at the Institute’s Vaccine Research Center as well as NIAID-supported scientists in external facilities are studying all aspects of Ebola and Marburg viruses, how they spread, and how they cause disease. Investigators seek better ways to diagnose and treat Ebola and Marburg fevers, including promising work on vaccines.
Liberia-U.S. Clinical Research Partnership Opens Trial to Test Ebola Treatments—Feb. 27, 2015
Media Availability: NIH Ebola Study in Macaques Provides Timeframes for Post-Mortem Viral Stability—Feb. 12, 2015
Ebola Vaccine Trial Opens in Liberia—Feb. 2, 2015
Q&A: PREVAIL Phase 2/3 Clinical Trial of Investigational Ebola Vaccines—Feb. 2, 2015
Media Availability: Scientists Report on Trial of Early-Generation Ebola, Marburg Vaccine Candidates—Dec. 23, 2014
Last Updated February 27, 2015